Polysorb nanoantibodies block SARS-CoV-2 infection and inhibit mutation escape
Tiantian Bio announced that TJ107 has completed the first patient drug treatment in Phase 2 clinical studies in China
AkzoNobel's 2014 sales were 14.296 billion euros, down 2%
Sanofi injects 2...
BioRxiv and Nature Sub-Journal Interpretation! A beneficial class of gut bacteria may play a key role in the treatment of type 2 diabetes!
What should we do about the SARS-CoV-2 virus mutants that have emerged in the UK?
Three companies have reached a strategic partnership on the type 2 diabetes drug Acapo sugar
New anti-inflammatory drugs! AbbVie IL-23 inhibitor Skyrizi's treatment of Crohn's disease (CD) 2 Phase III induction studies have been successful!
COVID-19 shelter? The study found that SARS-CoV-2 attacks the brain and can cause serious illness
Calcium Measurements from Whole Heart Using Rhod-2
(DHE) INP104:15 minutes effective, 2 hours of remission!
New anti-inflammatory drugs! AbbVie oral JAK1 inhibitor Rinvoq has been approved by the European Union to treat 2 new rheumatoids!
One year market value fell K drug sales in the last 2 years Mercadon 2021 can get back to a game?
Preparation of Escherichia coli Samples for 2-D Gel Analysis
JCEM: Relationship between stuttering and type 2 diabetes
Regenerative meta "stone man disease" new drug Phase 2 clinical success
Proteomics studies have helped identify potential drugs against SARS-CoV-2
: routine refrigeration, 2-pin immunity, global non-profit supply!
Aachen Pharmaceutical Bcl-2 inhibitor APG-2575 was qualified as an orphan drug
Science: Virus sequences can reveal how SARS-CoV-2 spreads and evolves